Drug Profile
Tadalafil oral film - CLPharm
Alternative Names: OGOODLatest Information Update: 01 Jan 2022
Price :
$50
*
At a glance
- Originator CLPharm
- Class Antihypertensives; Benzodioxoles; Carbolines; Erectile dysfunction therapies; Gastrokinetics; Heart failure therapies; Indoles; Ischaemic heart disorder therapies; Pyridones; Small molecules; Vascular disorder therapies; Vasodilators
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Erectile dysfunction
Most Recent Events
- 07 Feb 2019 Chemical structure information added
- 19 Dec 2017 Launched for Erectile dysfunction (In volunteers) in South Korea (PO) (CLPharm website, December 2017) before December 2017
- 10 Dec 2014 CLPharm completes a phase I trial in volunteers in South Korea (KCT0002360)